Free tool
FAERS Monitor: Zonisade
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 214273 or its brand name (Zonisade, Zonisamide). Reports on generic versions are filed under their own applications.
Reports
10,721
Serious
8,243
77% of reports
Hospitalization
3,294
Death reported
683
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective1,397
- seizure1,228
- off label use819
- fatigue501
- somnolence478
- dizziness402
- nausea387
- fall370
- headache364
- condition aggravated362
- drug interaction336
- vomiting321
- diarrhoea308
- epilepsy308
- convulsion294
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 29 |
| 2005 | 52 |
| 2006 | 99 |
| 2007 | 115 |
| 2008 | 139 |
| 2009 | 151 |
| 2010 | 165 |
| 2011 | 292 |
| 2012 | 320 |
| 2013 | 240 |
| 2014 | 292 |
| 2015 | 400 |
| 2016 | 544 |
| 2017 | 493 |
| 2018 | 674 |
| 2019 | 816 |
| 2020 | 726 |
| 2021 | 970 |
| 2022 | 968 |
| 2023 | 917 |
| 2024 | 881 |
| 2025 | 856 |
| 2026 | 582 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,438 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| seizureSignal | 1,228 | 21.1 | 20.0 | 23,336 |
| epilepsySignal | 308 | 20.0 | 17.9 | 5,479 |
| convulsionSignal | 294 | 10.1 | 9.1 | 2,405 |
| somnolenceSignal | 478 | 4.7 | 4.3 | 1,383 |
| drug interactionSignal | 336 | 4.2 | 3.7 | 808 |
| condition aggravatedSignal | 362 | 2.3 | 2.1 | 279 |
| fallSignal | 370 | 2.2 | 2.0 | 239 |
| drug ineffectiveSignal | 1,397 | 2.1 | 2.0 | 835 |
| off label use | 819 | 1.8 | 1.7 | 324 |
| dizziness | 402 | 1.6 | 1.4 | 87 |
| vomiting | 321 | 1.3 | 1.2 | 28 |
| fatigue | 501 | 1.3 | 1.2 | 28 |
| headache | 364 | 1.1 | 1.0 | 6 |
| nausea | 387 | 1.0 | 0.9 | 1 |
| diarrhoea | 308 | 0.9 | 0.8 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.